Sanofi US News

Net Sales and Business EPS(1) up 9.2%(2) in Q4

-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --

-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --

- NBA Star Carlos Boozer, WNBA All-Star Tamika Catchings, NBA Legend Bob Lanier and New Jersey Nets Head Coach Avery Johnson to Serve as Campaign Ambassadors -

JOINTLY RELEASED BY SANOFI AND THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

- Ruling Provides for Restricted U.S. Launch Prior to April Trial Date -

Innovative technology to enhance level of patient care, improve office efficiencies

- Highest recognition for a commitment to the renewal of US-European relations -

ImmYounity(SM) campaign unveiled as new resource for health-care professionals and consumers

Local Demonstration Program to Implement Community-Based Diabetes Management Announced

Sanofi Collaborates with Leading Health Organizations to Help Men Take More Proactive Stance in Managing Their Disease

- Performance driven by growth platforms, Genzyme acquisition and cost savings -

Elderly patients receiving the high-dose flu vaccine had a more robust immune response to vaccination with antibody levels similar to those typical in younger adults

Addition of fourth strain to influenza vaccine intended to address potential for a mismatch between strains selected for vaccine and circulating influenza viruses

- Findings from Two-Year Pivotal Phase III TEMSO Trial Published today in The New England Journal of Medicine -

Nationwide Recipe Contest Elevates Awareness for Proper Diabetes Management

New online community for managed care leaders

AFib Educator 2.0" Includes New Animations, Resources to Improve Patient-Physician Dialogue

Sanofi demonstrates commitment to wellness and prevention starts with its own employees

U.S. Senator Robert P. Casey, Jr. and Msgr. Joseph G. Quinn Co-Chair Record Breaking Event

Fluzone® Intradermal (Influenza Virus Vaccine) offers adults new immunization option for 2011-2012 influenza season

Fluzone® Intradermal (Influenza Virus Vaccine) offers adults new immunization option for 2011-2012 influenza season

-- Focused effort to reach mothers, the family's "chief medical officer"

National AFib Education Campaign Launches to Help Improve the Care of People with This Serious and Increasingly Prevalent(1) Form of Irregular Heartbeat

- Weight gain was lowest in patients with baseline A1C below 8 percent and in patients 65 years and older -

- New phase III data from GetGoal-F1 study of once-daily lixisenatide support simplified treatment initiation -

Four local non-profits receive donations totaling more than $180,000

Positive impact from Genzyme on business EPS(1)

Greg Irace, Senior Vice President, Global Services

Early shipments of Fluzone and Fluzone High-Dose vaccines support health-care providers in immunization planning and provide additional opportunities to increase immunization rates

- Strategic Divestiture to focus on Growth Platforms in the United States and Canada -

Company has sponsored high school biotechnology competition for almost 20 years

- Data Presented at American Diabetes Association's 71st Annual Scientific Sessions -

- Once-Daily Lyxumia® Demonstrates Non-Inferior Reduction of Blood Glucose and Less Hypoglycemia versus Exenatide Twice Daily in Type 2 Diabetes Patients -

U.S. locations launch a “Walking Club” and promote a myriad of programs offered to employees to improve overall health and wellness

- Over 500 Million Patients Suffer from Hearing Loss Worldwide with No Currently Available Disease-Modifying Treatments -

Diabetes Co-Stars: Cook-Off Invites People to Share Diabetes-Friendly Recipes

Donation Helps Four-time NASCAR Cup Series Champion Jeff Gordon Shift Relief Efforts into High Gear

- Results of Phase III SAVE-ONCO study selected for "Best of ASCO 2011" -

U.S. locations launch a “Walking Club” and promote a myriad of programs offered to employees to improve overall health and wellness

Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle

- Indication Provides New Option to Help Protect Earlier Against Meningococcal Disease -